286 related articles for article (PubMed ID: 27837031)
21. Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in
Appleton KM; Palsuledesai CC; Misek SA; Blake M; Zagorski J; Gallo KA; Dexheimer TS; Neubig RR
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33921974
[TBL] [Abstract][Full Text] [Related]
22. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
24. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.
Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S
Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044
[TBL] [Abstract][Full Text] [Related]
25. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
27. RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway.
Chen R; Cheng Y; Zhang Y; Li Z; Geng L
Int J Gynecol Cancer; 2014 Feb; 24(2):184-91. PubMed ID: 24457551
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
29. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
[TBL] [Abstract][Full Text] [Related]
30. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
Boone B; Brochez L
Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
[TBL] [Abstract][Full Text] [Related]
31. A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.
Figueiredo CR; Matsuo AL; Azevedo RA; Massaoka MH; Girola N; Polonelli L; Travassos LR
Sci Rep; 2015 Sep; 5():14310. PubMed ID: 26391685
[TBL] [Abstract][Full Text] [Related]
32. Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis.
Yu-Wai-Man C; Spencer-Dene B; Lee RMH; Hutchings K; Lisabeth EM; Treisman R; Bailly M; Larsen SD; Neubig RR; Khaw PT
Sci Rep; 2017 Mar; 7(1):518. PubMed ID: 28364121
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation acts positively and negatively to regulate MRTF-A subcellular localisation and activity.
Panayiotou R; Miralles F; Pawlowski R; Diring J; Flynn HR; Skehel M; Treisman R
Elife; 2016 Jun; 5():. PubMed ID: 27304076
[TBL] [Abstract][Full Text] [Related]
34. MRTF-A mediates the activation of COL1A1 expression stimulated by multiple signaling pathways in human breast cancer cells.
Meng C; He Y; Wei Z; Lu Y; Du F; Ou G; Wang N; Luo XG; Ma W; Zhang TC; He H
Biomed Pharmacother; 2018 Aug; 104():718-728. PubMed ID: 29807221
[TBL] [Abstract][Full Text] [Related]
35. Suppression of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells by an MRTF-A Inhibitor.
Kobayashi M; Tokuda K; Kobayashi Y; Yamashiro C; Uchi SH; Hatano M; Kimura K
Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):528-537. PubMed ID: 30707754
[TBL] [Abstract][Full Text] [Related]
36. MRTF potentiates TEAD-YAP transcriptional activity causing metastasis.
Kim T; Hwang D; Lee D; Kim JH; Kim SY; Lim DS
EMBO J; 2017 Feb; 36(4):520-535. PubMed ID: 28028053
[TBL] [Abstract][Full Text] [Related]
37. Mechanical strain induces a pro-fibrotic phenotype in human mitral valvular interstitial cells through RhoC/ROCK/MRTF-A and Erk1/2 signaling pathways.
Blomme B; Deroanne C; Hulin A; Lambert C; Defraigne JO; Nusgens B; Radermecker M; Colige A
J Mol Cell Cardiol; 2019 Oct; 135():149-159. PubMed ID: 31442470
[TBL] [Abstract][Full Text] [Related]
38. Targeting effector pathways in RAC1
Uribe-Alvarez C; Guerrero-Rodríguez SL; Rhodes J; Cannon A; Chernoff J; Araiza-Olivera D
Small GTPases; 2021 Jul; 12(4):273-281. PubMed ID: 32043900
[TBL] [Abstract][Full Text] [Related]
39. CX-F9, a novel RSK2 inhibitor, suppresses cutaneous melanoma cells proliferation and metastasis through regulating autophagy.
Zhang X; Cai L; Zhao S; Long J; Li J; Wu L; Su J; Zhang J; Tao J; Zhou J; Chen X; Peng C
Biochem Pharmacol; 2019 Oct; 168():14-25. PubMed ID: 31207212
[TBL] [Abstract][Full Text] [Related]
40. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
